Physician profile
Mark Koenig
NPI 1770521502
$10,793.00
in general payments reported to CMS, 2019-2025
39 companies · $3,116 in 2025
The $3,116 reported for 2025 was more than what 76% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,788 · 2020: $538 · 2021: $482 · 2022: $2,613 · 2023: $1,226 · 2024: $1,030 · 2025: $3,116.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,371 · Travel and Lodging: $1,986 · Education: $15.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,371.29 |
| Travel and Lodging | $1,985.54 |
| Education | $15.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,155.22 | 2024-2025 | Mo.Ma Ultra, Protege Rx, Chocolate Pta Balloon Catheter |
| Boston Scientific Corporation | $2,115.66 | 2019-2025 | Avvigo Guidance System, Watchman Access System |
| Abbott Laboratories | $1,318.41 | 2019-2024 | Hi-Torque Balance, Coroflow, Esprit |
| Penumbra, INC. | $602.60 | 2022-2023 | Indigo System |
| Recor Medical INC | $510.96 | 2024-2025 | Paradise Renal Denervation System, Paradise Ultrasound Renal Denervation System |
| Shockwave Medical, INC | $357.52 | 2021-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Novartis Pharmaceuticals Corporation | $330.43 | 2019-2024 | |
| Amgen INC. | $295.26 | 2020-2024 | Repatha |
| Janssen Pharmaceuticals, INC | $294.10 | 2021-2024 | Xarelto |
| Inari Medical, INC. | $276.51 | 2019-2022 | |
| Abiomed | $231.26 | 2022-2023 | Impella |
| Cook Medical LLC | $205.34 | 2023-2025 | Zilver Ptx |
| Bard Peripheral Vascular, INC. | $192.83 | 2019-2023 | Lutonix Drug Coated Balloon |
| Cardiovascular Systems INC. | $186.52 | 2019-2021 | |
| Surmodics, INC. | $182.69 | 2024 | Pounce Thrombectomy, Sublime 014 Rx Pta Balloon Dilatation Catheter, Sublime Microcatheter, 018, 200cm, Straight |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $151.98 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $138.36 | 2022-2024 | Eliquis |
| Esperion Therapeutics, INC. | $131.75 | 2023-2024 | Nexletol |
| Asahi Intecc USA, INC. | $130.94 | 2020 | |
| Stryker Corporation | $127.62 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Saranas, INC. | $123.76 | 2022 | |
| Terumo Medical Corporation | $117.50 | 2025 | Tr Band, Navicross, Glidesheath Slender |
| Bayer Healthcare Pharmaceuticals INC. | $105.87 | 2025 | |
| Astrazeneca Pharmaceuticals Lp | $83.23 | 2019-2024 | Farxiga |
| Philips North America LLC | $75.14 | 2022 | |
| Heartflow, INC. | $47.66 | 2023 | Ffrct |
| Pfizer INC. | $42.35 | 2023-2024 | |
| Inspire Medical Systems, INC. | $42.23 | 2023 | Inspire |
| Lexicon Pharmaceuticals, INC. | $41.98 | 2023-2024 | Inpefa |
| Teleflex LLC | $31.58 | 2022 | |
| Abbvie INC. | $24.33 | 2021 | |
| Allergan, INC. | $21.54 | 2020 | |
| Novo Nordisk INC | $21.07 | 2024 | |
| Merck Sharp & Dohme LLC | $17.98 | 2023 | Verquvo |
| Medtronic Vascular, INC. | $17.53 | 2020 | |
| Baxter Healthcare | $15.29 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.81 | 2023 | Jardiance |
| Kiniksa Pharmaceuticals, Ltd. | $13.19 | 2023 | Arcalyst |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Koenig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.